RPTX and GILD Related Headlines

Go Back

Dec 24, 2025 07:00AM Gilead Sciences acquires Repare drug candidate for up to $30 million

RPTX and GILD Related Press Releases

Go Back

RPTX and GILD Related SEC Filings

Go Back